Owen Wallace is the founder of Monte Rosa Therapeutics. Backed by Versant Ventures, Aisling Capital, GV. Based in Boston, USA.
Owen Wallace was the Chief Scientific Officer at Monte Rosa Therapeutics, a clinical-stage biotechnology company focused on developing molecular glue degrader (MGD)-based medicines. He played a key role in developing the company's QuEEN™ drug discovery engine and advancing MGD drug candidates. Before Monte Rosa, he was CSO at Fulcrum Therapeutics and held global discovery chemistry roles at Novartis and Eli Lilly.
Full founder directory · Investor directory · Company funding database · Fundraising library